Lee Johnson Capital Management LLC Has $1.04 Million Position in Axon Enterprise, Inc $AXON

Lee Johnson Capital Management LLC trimmed its holdings in Axon Enterprise, Inc (NASDAQ:AXON) by 83.3% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,452 shares of the biotechnology company’s stock after selling 7,235 shares during the quarter. Lee Johnson Capital Management LLC’s holdings in Axon Enterprise were worth $1,042,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds also recently made changes to their positions in AXON. Banque Transatlantique SA acquired a new position in Axon Enterprise in the first quarter valued at approximately $31,000. Flaharty Asset Management LLC acquired a new stake in shares of Axon Enterprise in the 1st quarter valued at about $33,000. Hemington Wealth Management raised its position in shares of Axon Enterprise by 70.8% during the second quarter. Hemington Wealth Management now owns 41 shares of the biotechnology company’s stock worth $33,000 after purchasing an additional 17 shares during the period. Whipplewood Advisors LLC grew its position in Axon Enterprise by 192.9% in the 2nd quarter. Whipplewood Advisors LLC now owns 41 shares of the biotechnology company’s stock valued at $34,000 after purchasing an additional 27 shares during the period. Finally, Darwin Wealth Management LLC bought a new stake in Axon Enterprise during the 2nd quarter valued at $37,000. Institutional investors own 79.08% of the company’s stock.

Insider Activity

In related news, President Joshua Isner sold 20,000 shares of Axon Enterprise stock in a transaction that occurred on Monday, December 8th. The shares were sold at an average price of $552.60, for a total value of $11,052,000.00. Following the completion of the transaction, the president directly owned 249,502 shares in the company, valued at approximately $137,874,805.20. The trade was a 7.42% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Patrick W. Smith sold 10,000 shares of the business’s stock in a transaction on Monday, December 8th. The shares were sold at an average price of $551.92, for a total transaction of $5,519,200.00. Following the sale, the chief executive officer directly owned 3,110,997 shares in the company, valued at $1,717,021,464.24. The trade was a 0.32% decrease in their position. The SEC filing for this sale provides additional information. Over the last three months, insiders have sold 60,540 shares of company stock valued at $35,632,038. 5.70% of the stock is currently owned by corporate insiders.

Analysts Set New Price Targets

Several research firms have recently commented on AXON. The Goldman Sachs Group decreased their target price on shares of Axon Enterprise from $940.00 to $800.00 and set a “buy” rating for the company in a research report on Wednesday, November 5th. Royal Bank Of Canada began coverage on Axon Enterprise in a research report on Monday, November 17th. They set an “outperform” rating and a $860.00 target price on the stock. Morgan Stanley lowered their price target on Axon Enterprise from $760.00 to $713.00 and set an “overweight” rating for the company in a research report on Wednesday, December 17th. Cowen restated a “buy” rating on shares of Axon Enterprise in a research note on Wednesday, November 5th. Finally, Piper Sandler cut their price objective on shares of Axon Enterprise from $893.00 to $753.00 and set an “overweight” rating on the stock in a report on Wednesday, November 5th. Fourteen equities research analysts have rated the stock with a Buy rating and four have given a Hold rating to the stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $802.71.

Axon Enterprise Price Performance

Shares of NASDAQ:AXON opened at $572.11 on Wednesday. Axon Enterprise, Inc has a fifty-two week low of $469.24 and a fifty-two week high of $885.91. The company’s 50-day moving average is $594.96 and its 200 day moving average is $697.64. The company has a debt-to-equity ratio of 0.57, a quick ratio of 2.89 and a current ratio of 3.12. The company has a market capitalization of $45.15 billion, a P/E ratio of 181.05, a price-to-earnings-growth ratio of 133.34 and a beta of 1.40.

Axon Enterprise (NASDAQ:AXON) last released its earnings results on Wednesday, November 5th. The biotechnology company reported $1.17 earnings per share for the quarter, missing analysts’ consensus estimates of $1.63 by ($0.46). Axon Enterprise had a net margin of 10.05% and a return on equity of 4.29%. The company had revenue of $710.64 million during the quarter, compared to analysts’ expectations of $704.83 million. During the same quarter in the previous year, the firm earned $1.45 earnings per share. The firm’s revenue was up 30.6% compared to the same quarter last year. On average, equities research analysts forecast that Axon Enterprise, Inc will post 5.8 earnings per share for the current year.

Axon Enterprise Profile

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.